Merrion Investment Management Co, LLC Amgen Inc Transaction History

Merrion Investment Management Co, LLC

$146 Million
Q3 2024

A detailed history of Merrion Investment Management Co, LLC transactions in Amgen Inc stock. As of the latest transaction made, Merrion Investment Management Co, LLC holds 2,593 shares of AMGN stock, worth $763,716. This represents 0.57% of its overall portfolio holdings.

Number of Shares

2,593

Previous 2,593 -0.0%

Holding current value

$763,716

Previous $810,000 3.09%

% of portfolio

0.57%

Previous 0.58%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$262.75 - $319.31 $13,137 - $15,965	-50 Reduced 1.89%	2,593 $810,000
Q1 2024 Apr 17, 2024	BUY	$268.87 - $324.56 $47,052 - $56,798	175 Added 7.09%	2,643 $751,000
Q4 2023 Jan 12, 2024	BUY	$255.7 - $288.46 $108,672 - $122,595	425 Added 20.8%	2,468 $710,000
Q3 2023 Oct 19, 2023	SELL	$218.65 - $271.46 $43,730 - $54,291	-200 Reduced 8.92%	2,043 $549,000
Q4 2022 Jan 24, 2023	SELL	$229.03 - $291.01 $41,225 - $52,381	-180 Reduced 7.43%	2,243 $0
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $18,456 - $20,539	-80 Reduced 3.2%	2,423 $590,000
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $109,635 - $121,285	-500 Reduced 16.65%	2,503 $605,000
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $2,122 - $2,487	-10 Reduced 0.33%	3,003 $638,000
Q2 2021 Jul 28, 2021	SELL	$233.58 - $259.14 $27,796 - $30,837	-119 Reduced 3.8%	3,013 $734,000
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $677,702 - $807,022	3,132 New	3,132 $720,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Merrion Investment Management Co, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merrion Investment Management Co, LLC with notifications on news.

Account

Merrion Investment Management Co, LLC Amgen Inc Transaction History